102 related articles for article (PubMed ID: 184915)
1. Primary liver cell carcinoma in the presence or absence of hepatitis B antigen.
Fisher RL; Scheuer PJ; Sherlock S
Cancer; 1976 Aug; 38(2):901-5. PubMed ID: 184915
[TBL] [Abstract][Full Text] [Related]
2. [The occurrence and significance of the presence of alpha fetoprotein (AFP) and Australia antigen (HBsAg) in the serum of 392 patients with chronic disease and primary malignant neoplasms of the liver].
Stajić M; Milosavljević J
Acta Med Iugosl; 1978; 32(3):243-51. PubMed ID: 80098
[No Abstract] [Full Text] [Related]
3. Expression of hepatitis B surface antigen subtypes in liver of patients with hepatocellular carcinoma; comparison of subtypes in serum and liver.
Nakatsuji Y; Kiyosawa K; Tanaka E; Sodeyama T; Horigome N; Kajikawa S; Naito S; Akahane Y
Liver; 1991 Jun; 11(3):176-84. PubMed ID: 1653386
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B antigen in the liver in hepatocellular carcinoma in Shikoku, Japan.
Akagi G; Furuya K; Otsuka H
Cancer; 1982 Feb; 49(4):678-82. PubMed ID: 6275977
[TBL] [Abstract][Full Text] [Related]
5. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
Okuda H; Obata H; Motoike Y; Hisamitsu T
Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
[TBL] [Abstract][Full Text] [Related]
7. Primary hepatocellular carcinoma and hepatitis B infection during childhood.
Wu TC; Tong MJ; Hwang B; Lee SD; Hu MM
Hepatology; 1987; 7(1):46-8. PubMed ID: 2433204
[TBL] [Abstract][Full Text] [Related]
8. HBsAg-negative hepatitis B virus infection and hepatocellular carcinoma.
Chen L; Zhao H; Yang X; Gao JY; Cheng J
Discov Med; 2014 Oct; 18(99):189-93. PubMed ID: 25336032
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
11. [Serum alpha-fetoprotein and hepatitis B surface antigen in patients with hepatocellular carcinoma (author's transl)].
Kao MC; Yin SJ; Lee SC; Lin CY; Cheng TC; Fong MS
Taiwan Yi Xue Hui Za Zhi; 1980 Nov; 79(11):1032-7. PubMed ID: 6166727
[No Abstract] [Full Text] [Related]
12. Hepatocellular carcinoma. A study of 50 autopsy cases with detection of hepatitis B surface antigen in fixed tissues.
Perez-Barrios A; Colina-Ruizdelgado F; Gallego I; Martinez-Tello FJ
Pathol Res Pract; 1983 Mar; 176(2-4):131-44. PubMed ID: 6190153
[TBL] [Abstract][Full Text] [Related]
13. Alpha 1-antitrypsin levels and phenotypes and hepatitis B serology in liver cancer.
Sparos L; Tountas Y; Chapuis-Cellier C; Theodoropoulos G; Trichopoulos D
Br J Cancer; 1984 May; 49(5):567-70. PubMed ID: 6326791
[TBL] [Abstract][Full Text] [Related]
14. Serum alphafetoprotein in hepatocellular carcinoma.
Chen DS; Sung JL
Cancer; 1977 Aug; 40(2):779-83. PubMed ID: 70268
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B antigen and alpha fetoprotein in the sera of patients with hepatocellular carcinoma.
Rajagopalan N; Sama SK; Krishnamurthy L; Gandhi G; Nayak NC
Indian J Med Res; 1977 Jan; 65(1):95-100. PubMed ID: 68001
[No Abstract] [Full Text] [Related]
16. Evolution of expression of hepatitis B surface and core antigens (HBsAg, HBcAg) in resected primary and recurrent hepatocellular carcinoma in HBsAg carriers in Taiwan. Correlation with local host immune response.
Hsu HC; Wu TT; Wu MZ; Wu CY; Chiou TJ; Sheu JC; Lee CS; Chen DS
Cancer; 1988 Sep; 62(5):915-21. PubMed ID: 2842026
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection.
Tong MJ; Weiner JM; Ashcavai MW; Redeker AG; Comparini S; Vyas GN
J Infect Dis; 1979 Oct; 140(4):506-12. PubMed ID: 229173
[TBL] [Abstract][Full Text] [Related]
18. Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver.
Hirohashi S; Shimosato Y; Ino Y; Kishi K
J Natl Cancer Inst; 1982 Sep; 69(3):565-8. PubMed ID: 6287080
[TBL] [Abstract][Full Text] [Related]
19. Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
Yip TC; Chan HL; Wong VW; Tse YK; Lam KL; Wong GL
J Hepatol; 2017 Nov; 67(5):902-908. PubMed ID: 28652084
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
